PRME Competitors & Alternatives
Compare Prime Medicine, Inc. Common Stock with similar stocks in the same industry
Biotechnology
PRME
Main Stock$3.24
Tradestie Score
61
Market Cap
$996.55M
Revenue Growth
-0.4%
Analyst Upside
+113.5%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.13
|
$688.47M | - | 55 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ANL
ANL
|
$10.60
|
$669.74M | - | 53 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.81
|
$665.30M | - | 57 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.07
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$5.78
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.15
|
$552.46M | - | 57 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.63
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.00
|
$529.35M | 6.3 | 64 | Compare |
More PRME Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry